Invesaro

Stocks TREE Financial statements

Financial statements

LendingTree, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LendingTree, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue3846187651,1079101,0989856739001,117
Cost of revenue13.817.236.468.454.557.357.838.836.142.5
Gross profit371251305432369410369290310352
Research and development13.817.9274043.652.955.647.246.445.3
Selling and marketing261433500735617774702434636813
General and administrative37.271.5101117129153152118109113
Operating income52.133.156.250.7-6.68.03-32.8-40.644.664.8
Interest expense0.567.0312.420.336.346.926
Other non-operating income1233.84-106-54.23
Pre-tax income51.625.743.731-42.584.4-54.9-125-37.421
Income tax20.46.29-65.6-8.48-2011.3133-2.524.32-130
Income from continuing operations31.219.410939.5-22.673.1-188-122
Net income27.515.696.517.8-48.369.1-188-122-41.7151
EBITDA57.140.263.661.77.625.9-12.7-21.562.981.3
EPS, basic2.331.307.721.39-3.715.24-14.69-9.46-3.1411.14
EPS, diluted2.151.146.851.22-3.715.05-14.69-9.46-3.1410.78
Shares, basic (weighted)11.811.912.512.81313.212.812.913.313.6
Shares, diluted (weighted)12.813.714.114.61313.712.812.913.314.1

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents91.136910560.217025129911210781.1
Receivables41.453.491.111389.897.783.15597.8111
Other current assets4.0211.916.415.527.925.426.329.534.138.1
Total current assets141438234189296374414196238230
Property, plant and equipment35.536.423.231.462.472.559.250.542.832.8
Lease right-of-use assets25.584.177.367.157.252.631.7
Goodwill56.5113348420420420420382382382
Intangible assets71.781.120618212985.858.350.643.338.1
Other non-current assets0.811.912.174.335.336.946.16.347.3517
Total assets3236938969481,1891,2991,199803768856
Accounts payable5.599.2515.12.8710.11.692.031.968.366.74
Accrued liabilities49.477.293.211310110775.170.5107127
Deferred revenue0.40.60.70.80.90
Short-term debt01257501662.53.131253.93
Total current liabilities66.714826223111227482.575.6240137
Long-term debt0238251264611478814526344388
Lease liabilities21.492.496.288.27569.243.6
Other non-current liabilities1.691.68.364.750.360.350.310.270.130.14
Total liabilities92399550546824851991679659569
Total debt0238376339611644816529469392
Paid-in capital1,0181,0881,1341,1781,1891,2431,1891,2281,2541,281
Retained earnings-723-708-610-593-641-572-715-838-879-728
Treasury stock-64.1-85.1-178-183-183-223-266-266-266-266
Shareholders' equity231295346402365448208124109287
Total equity231295346402365448208124109287
Total liabilities and equity3236938969481,1891,2991,199803768856
Shares outstanding11.81212.81313.113.112.81313.413.8

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income27.515.696.517.8-48.369.1-188-122-41.7151
Depreciation and amortization4.947.097.391114.217.920.119.118.316.5
Stock-based compensation9.6523.444.452.253.768.659.639.728.629.5
Deferred income tax6.37-6.37-63.9-8.56-9.6310.9133-4.692.79-130
Change in receivables-8.36-11.4-16.8-22.521.9-10.39.1427.7-43-13.1
Cash from operations64.21041241571111314367.662.373.1
Capital expenditures-32-8.04-14.9-20-42.1-35.1-11.4-12.5-11.2-12.4
Acquisitions-81.2
Cash from investing-120-74.4-383-101-12210.1-27.9-12.5-11.2-9.93
Stock issued-4.091.62.228.77.72.200
Share buybacks-48.5-19.9-93.7-5.470-40-4300
Dividends paid00
Cash from financing-52.62534.84-87.7193-63.332.5-242-56.5-88.7
Net change in cash-116277-267-44.811081.347.6-187-5.46-25.5
Free cash flow32.395.510913769.296.231.5555160.7
Interest paid0.321.333.597.014.748.911923.738.237.2
Income taxes paid3.120.40.540.030.560.190.41.281.681.53

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $24.62 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin29.8%Gross profit / revenue.
Operating margin8.2%Operating income / revenue.
EBITDA margin9.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin4.9%Pre-tax income / revenue.
Net margin14.3%Net income / revenue.
FCF margin5.8%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin6.8%Cash from operations / revenue.
Effective tax rate-192.4%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)56.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)19.9%Net income / average total assets.
Return on invested capital (ROIC)13.7%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue3.4%Research and development expense / revenue.
Stock-based pay / revenue1.9%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.0%Capital expenditures / revenue.
D&A / revenue1.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y24.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y4.3%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y4.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y13.7%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-1.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-1.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y45.2%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y29.2%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 5y60.6%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y17.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y19.4%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-8.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y18.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y24.4%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-2.6%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y163.5%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y11.3%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-4.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y11.5%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-10.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-6.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y6.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y3.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y1.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.85xCurrent assets / current liabilities.
Quick ratio1.60x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.68x(Cash + short-term investments) / current liabilities.
Debt / equity1.22xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets42.8%Total debt / total assets.
Liabilities / assets64.8%Total liabilities / total assets.
Net debt$279.5MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA2.32xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$137.4MCurrent assets - current liabilities.
Goodwill and intangibles / assets45.7%(Goodwill + intangible assets) / total assets.
Tangible book value-$96.3MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.39xRevenue / average total assets.
Fixed asset turnover41.7xRevenue / average property, plant and equipment.
Receivables turnover8.49xRevenue / average receivables.
Days sales outstanding43 days365 x average receivables / revenue.
Days payables379 days365 x average accounts payable / cost of revenue.
FCF conversion40.7%Free cash flow / net income, when net income is positive.
Capex / operating cash flow14.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$12.93Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$90.24Revenue / diluted weighted shares.
FCF per share$5.26Free cash flow / diluted weighted shares.
Operating cash flow per share$6.12Cash from operations / diluted weighted shares.
Book value per share$22.86Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$6.86Tangible book value / shares outstanding.
Cash per share$7.89(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$345.7MShare price x shares outstanding.
Enterprise value$625.2MMarket cap + total debt - cash - short-term investments.
P/E1.90xMarket cap / net income. Only when net income is positive.
P/S0.27xMarket cap / revenue.
P/B1.08xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF4.68xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF4.02xMarket cap / cash from operations, when positive.
EV/Sales0.49xEnterprise value / revenue.
EV/EBIT6.02xEnterprise value / operating income, when both are positive.
EV/EBITDA5.20xEnterprise value / EBITDA, when both are positive.
EV/FCF8.46xEnterprise value / free cash flow, when both are positive.
FCF yield21.4%Free cash flow / market cap.
Earnings yield52.6%Net income / market cap (the inverse of P/E).
What was LendingTree, Inc.'s revenue in fiscal 2025?

LendingTree, Inc. reported revenue of $1.12B for fiscal 2025, 24.1% higher than the year before.

Was LendingTree, Inc. profitable in fiscal 2025?

Yes. Net income was $151.3M, a net margin of 13.5%.

How much free cash flow did LendingTree, Inc. generate in fiscal 2025?

Cash from operations of $73.1M minus capital expenditures of $12.4M left free cash flow of $60.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to LendingTree, Inc.